Cargando…

Nrf2 and the Nrf2-Interacting Network in Respiratory Inflammation and Diseases

Atmospheric pollutants and cigarette smoke influence the human respiratory system and induce airway inflammation, injury, and pathogenesis. Activation of the NF-E2-related factor 2 (Nrf2) transcription factor and downstream antioxidant response element (ARE)-mediated transcriptions play a central ro...

Descripción completa

Detalles Bibliográficos
Autores principales: Carlson, Jennifer, Price, Lindsey, Deng, Huai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241096/
http://dx.doi.org/10.1007/978-3-030-44599-7_3
_version_ 1783537023413387264
author Carlson, Jennifer
Price, Lindsey
Deng, Huai
author_facet Carlson, Jennifer
Price, Lindsey
Deng, Huai
author_sort Carlson, Jennifer
collection PubMed
description Atmospheric pollutants and cigarette smoke influence the human respiratory system and induce airway inflammation, injury, and pathogenesis. Activation of the NF-E2-related factor 2 (Nrf2) transcription factor and downstream antioxidant response element (ARE)-mediated transcriptions play a central role in protecting respiratory cells against reactive oxidative species (ROS) that are induced by airway toxins and inflammation. Recent studies have revealed that Nrf2 can also target and activate many genes involved in developmental programs such as cell proliferation, cell differentiation, cell death, and metabolism. Nrf2 is closely regulated by the interaction with kelch-like ECH-associated protein 1 (Keap1), while also directly interacts with a number of other proteins, including inflammatory factors, transcription factors, autophagy mediators, kinases, epigenetic modifiers, etc. It is believed that the multiple target genes and the complicated interacting network of Nrf2 account for the roles of Nrf2 in physiologies and pathogeneses. This chapter summarizes the molecular functions and protein interactions of Nrf2, as well as the roles of Nrf2 and the Nrf2-interacting network in respiratory inflammation and diseases, including acute lung injury (ALI), asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis (PF), cystic fibrosis (CF), viral/bacterial infections, and lung cancers. Therapeutic applications that target Nrf2 and its interacting proteins in respiratory diseases are also reviewed.
format Online
Article
Text
id pubmed-7241096
institution National Center for Biotechnology Information
language English
publishDate 2020
record_format MEDLINE/PubMed
spelling pubmed-72410962020-05-21 Nrf2 and the Nrf2-Interacting Network in Respiratory Inflammation and Diseases Carlson, Jennifer Price, Lindsey Deng, Huai Nrf2 and its Modulation in Inflammation Article Atmospheric pollutants and cigarette smoke influence the human respiratory system and induce airway inflammation, injury, and pathogenesis. Activation of the NF-E2-related factor 2 (Nrf2) transcription factor and downstream antioxidant response element (ARE)-mediated transcriptions play a central role in protecting respiratory cells against reactive oxidative species (ROS) that are induced by airway toxins and inflammation. Recent studies have revealed that Nrf2 can also target and activate many genes involved in developmental programs such as cell proliferation, cell differentiation, cell death, and metabolism. Nrf2 is closely regulated by the interaction with kelch-like ECH-associated protein 1 (Keap1), while also directly interacts with a number of other proteins, including inflammatory factors, transcription factors, autophagy mediators, kinases, epigenetic modifiers, etc. It is believed that the multiple target genes and the complicated interacting network of Nrf2 account for the roles of Nrf2 in physiologies and pathogeneses. This chapter summarizes the molecular functions and protein interactions of Nrf2, as well as the roles of Nrf2 and the Nrf2-interacting network in respiratory inflammation and diseases, including acute lung injury (ALI), asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis (PF), cystic fibrosis (CF), viral/bacterial infections, and lung cancers. Therapeutic applications that target Nrf2 and its interacting proteins in respiratory diseases are also reviewed. 2020-05-22 /pmc/articles/PMC7241096/ http://dx.doi.org/10.1007/978-3-030-44599-7_3 Text en © Springer Nature Switzerland AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Carlson, Jennifer
Price, Lindsey
Deng, Huai
Nrf2 and the Nrf2-Interacting Network in Respiratory Inflammation and Diseases
title Nrf2 and the Nrf2-Interacting Network in Respiratory Inflammation and Diseases
title_full Nrf2 and the Nrf2-Interacting Network in Respiratory Inflammation and Diseases
title_fullStr Nrf2 and the Nrf2-Interacting Network in Respiratory Inflammation and Diseases
title_full_unstemmed Nrf2 and the Nrf2-Interacting Network in Respiratory Inflammation and Diseases
title_short Nrf2 and the Nrf2-Interacting Network in Respiratory Inflammation and Diseases
title_sort nrf2 and the nrf2-interacting network in respiratory inflammation and diseases
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241096/
http://dx.doi.org/10.1007/978-3-030-44599-7_3
work_keys_str_mv AT carlsonjennifer nrf2andthenrf2interactingnetworkinrespiratoryinflammationanddiseases
AT pricelindsey nrf2andthenrf2interactingnetworkinrespiratoryinflammationanddiseases
AT denghuai nrf2andthenrf2interactingnetworkinrespiratoryinflammationanddiseases